Oral contraceptive use and the risk of cardiac events in patients with long QT syndrome

Heart Rhythm

Volumn 11, Issue 7, 2014, Pages 1170-1175

  Abu Zeitone, Abeer ^a   Peterson, Derick R ^a   Polonsky, Bronislava ^a   McNitt, Scott ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cardiac events; Estrogen; Long QT syndrome; Oral contraceptive therapy; Pregnancy; Progesterone; Sex hormones

Indexed keywords

ESTROGEN; PROGESTERONE; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONAL THERAPY; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME 1; LONG QT SYNDROME 2; LONG QT SYNDROME 3; MAJOR CLINICAL STUDY; ORAL CONTRACEPTIVE USE; PRIORITY JOURNAL; RISK ASSESSMENT; COMPLICATION; FOLLOW UP; HEART ARREST; INCIDENCE; MIDDLE AGED; PREGNANCY; REGISTER; RISK FACTOR;

ADULT; CONTRACEPTIVES, ORAL; FEMALE; FOLLOW-UP STUDIES; HEART ARREST; HUMANS; INCIDENCE; LONG QT SYNDROME; MIDDLE AGED; PREGNANCY; REGISTRIES; RISK FACTORS;

EID: 84903304231     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.04.016     Document Type: Article

References (25)

1. M. Keating, D. Atkinson, C. Dunn, K. Timothy, G.M. Vincent, and M. Leppert Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene Science 5006 1991 704 706
2. M. Keating, C. Dunn, D. Atkinson, K. Timothy, G.M. Vincent, and M. Leppert Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11 Am J Hum Genet 6 1991 1335 1339
3. M.E. Curran, I. Splawski, K.W. Timothy, G.M. Vincent, E.D. Green, and M.T. Keating A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome Cell 5 1995 795 803
4. M.C. Sanguinetti, C. Jiang, M.E. Curran, and M.T. Keating A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel Cell 2 1995 299 307
5. E.J. Rashba, W. Zareba, A.J. Moss, W.J. Hall, J. Robinson, E.H. Locati, P.J. Schwartz, and M. Andrews LQTS Investigators. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome Circulation 5 1998 451 456
6. R. Seth, A.J. Moss, and S. McNitt et al. Long QT syndrome and pregnancy J Am Coll Cardiol 10 2007 1092 1098
7. M.D. Drici, T.R. Burklow, V. Haridasse, R.I. Glazer, and R.L. Woosley Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart Circulation 6 1996 1471 1474
8. H. Nakamura, J. Kurokawa, C.X. Bai, K. Asada, J. Xu, R.V. Oren, Z.I. Zhu, C.E. Clancy, M. Isobe, and T. Furukawa Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study Circulation 25 2007 2913 2922
9. J. Kurokawa, M. Tamagawa, N. Harada, S. Honda, C.X. Bai, H. Nakaya, and T. Furukawa Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization J Physiol 12 2008 2961 2973
10. F. Ando, A. Kuruma, and S. Kawano Synergic effects of β-estradiol and erythromycin on hERG currents J Membr Biol 1 2011 31 38
11. K.E. Odening, B.R. Choi, G.X. Liu, K. Hartmann, O. Ziv, L. Chaves, L. Schofield, J. Centracchio, M. Zehender, X. Peng, M. Brunner, and G. Koren Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective Heart Rhythm 5 2012 823 832
12. D. Cox Regression models and life tables (with discussion) J R Stat Soc B 34 1972 187 220
13. J.B. Hobbs, D.R. Peterson, and A.J. Moss et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome JAMA 10 2006 1249 1254
14. A.J. Sauer, A.J. Moss, and S. McNitt et al. Long QT syndrome in adults J Am Coll Cardiol 3 2007 329 337
15. I. Goldenberg, A.J. Moss, and D.R. Peterson et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome Circulation 17 2008 2184 2191
16. E.H. Locati, W. Zareba, and A.J. Moss et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry Circulation 22 1998 2237 2244
17. M. Dhont History of oral contraception Eur J Contracept Reprod Health Care 15 2010 S12 S18
18. V. Hendrick, L.L. Altshuler, and R. Suri Hormonal changes in the postpartum and implications for postpartum depression Psychosomatics 2 1998 93 101
19. A.W. Norman, and G. Litwack Estrogens and progestins A.W. Norman, G. Litwack, Hormones 1997 Academic Press San Diego, CA 361 386
20. J.S. Mitcheson, J. Chen, M. Lin, C. Culberson, and M.C. Sanguinetti A structural basis for drug-induced long QT syndrome Proc Natl Acad Sci U S A 22 2000 12329 12333
21. J. Mitcheson, M. Perry, P. Stansfeld, M.C. Sanguinetti, H. Witchel, and J. Hancox Structural determinants for high-affinity block of hERG potassium channels Novartis Found Symp 266 2005 136 150 discussion 150-158
22. M. Perry, M. Sanguinetti, and J. Mitcheson Revealing the structural basis of action of hERG potassium channel activators and blockers J Physiol 17 2010 3157 3167
23. C. Donger, I. Denjoy, M. Berthet, N. Neyroud, C. Cruaud, M. Bennaceur, G. Chivoret, K. Schwartz, P. Coumel, and P. Guicheney KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome Circulation 9 1997 2778 2781
24. C. Napolitano, P.J. Schwartz, A.M. Brown, E. Ronchetti, L. Bianchi, A. Pinnavaia, G. Acquaro, and S.G. Priori Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias J Cardiovasc Electrophysiol 6 2000 691 696
25. T. Sedlak, C. Shufelt, C. Iribarren, L.L. Lyon, and C.N. Bairey Merz Oral contraceptive use and the ECG: evidence of an adverse QT effect on corrected QT interval Ann Noninvasive Electrocardiol 4 2013 389 398